# 2026-16713: FDA Times BIZENGRI's Patent Extension Review – Clockwork Bureaucracy

2026-16713, Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-08-17, effective Anyone with knowledge that any of the dates as published (see SUPPLEMENTARY INFORMATION) are incorrect may submit either electronic or written comments and ask for a redetermination by October 16, 2026. Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by February 16, 2027. See "Petitions" in the SUPPLEMENTARY INFORMATION section for more information. (as of 2026-08-24).

- Canonical: https://policyrisk.com/federal-register/2026-16713
- As of: 2026-08-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-16713
- Title: Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 53261
- Published: 2026-08-17
- Effective: Anyone with knowledge that any of the dates as published (see SUPPLEMENTARY INFORMATION) are incorrect may submit either electronic or written comments and ask for a redetermination by October 16, 2026. Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by February 16, 2027. See "Petitions" in the SUPPLEMENTARY INFORMATION section for more information.
- Comments close: 2026-10-16
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-08-24

## In one line

FDA Times BIZENGRI's Patent Extension Review – Clockwork Bureaucracy

## Summary

The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for BIZENGRI and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-16713 on federalregister.gov](https://www.federalregister.gov/documents/2026/08/17/2026-16713/determination-of-regulatory-review-period-for-purposes-of-patent-extension-bizengri)
- [2026-16713 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-08-17/pdf/2026-16713.pdf)

## Related
- [Previous: 2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request;…](https://policyrisk.com/federal-register/2026-16712)
- [Next: 2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request;…](https://policyrisk.com/federal-register/2026-16714)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-16713 (as of 2026-08-24).
